25 Jul 2022 , 05:31 PM
Net profit of Tatva Chintan Pharma Chem declined 57.67% to Rs 9.80 crore in the quarter ended June 2022 as against Rs 23.15 crore during the previous quarter ended June 2021. Sales declined 17.25% to Rs 88.40 crore in the quarter ended June 2022 as against Rs 106.83 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 88.40 | 106.83 | -17 |
| OPM % | 17.22 | 24.18 | – |
| PBDT | 16.03 | 26.16 | -39 |
| PBT | 13.70 | 24.26 | -44 |
| NP | 9.80 | 23.15 | -58 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
